Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous Injection market report explains the definition, types, applications, major countries, and major players of the Subcutaneous Injection market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Takeda Pharmaceutical
Asahi Kasei Pharma
GSK
Sanofi
Becton Dickinson
PenJet Corporation
Endo International
Aspen Medical Group
Eli Lilly
Roche
Chugai Pharmaceutical
Eisai CO LTD
Antares Pharma Inc
Daiichi Sankyo
By Type:
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
By End-User:
Hospital
Clinic
Laboratory
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Subcutaneous Injection Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Subcutaneous Injection Outlook to 2028- Original Forecasts
-
2.2 Subcutaneous Injection Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Subcutaneous Injection Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Subcutaneous Injection Market- Recent Developments
-
6.1 Subcutaneous Injection Market News and Developments
-
6.2 Subcutaneous Injection Market Deals Landscape
7 Subcutaneous Injection Raw Materials and Cost Structure Analysis
-
7.1 Subcutaneous Injection Key Raw Materials
-
7.2 Subcutaneous Injection Price Trend of Key Raw Materials
-
7.3 Subcutaneous Injection Key Suppliers of Raw Materials
-
7.4 Subcutaneous Injection Market Concentration Rate of Raw Materials
-
7.5 Subcutaneous Injection Cost Structure Analysis
-
7.5.1 Subcutaneous Injection Raw Materials Analysis
-
7.5.2 Subcutaneous Injection Labor Cost Analysis
-
7.5.3 Subcutaneous Injection Manufacturing Expenses Analysis
8 Global Subcutaneous Injection Import and Export Analysis (Top 10 Countries)
-
8.1 Global Subcutaneous Injection Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Subcutaneous Injection Export by Region (Top 10 Countries) (2017-2028)
9 Global Subcutaneous Injection Market Outlook by Types and Applications to 2022
-
9.1 Global Subcutaneous Injection Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Subcutaneous Injection Equipment Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Subcutaneous Injection Drug Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Subcutaneous Injection Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Laboratory Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Subcutaneous Injection Market Analysis and Outlook till 2022
-
10.1 Global Subcutaneous Injection Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Subcutaneous Injection Consumption (2017-2022)
-
10.2.2 Canada Subcutaneous Injection Consumption (2017-2022)
-
10.2.3 Mexico Subcutaneous Injection Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Subcutaneous Injection Consumption (2017-2022)
-
10.3.2 UK Subcutaneous Injection Consumption (2017-2022)
-
10.3.3 Spain Subcutaneous Injection Consumption (2017-2022)
-
10.3.4 Belgium Subcutaneous Injection Consumption (2017-2022)
-
10.3.5 France Subcutaneous Injection Consumption (2017-2022)
-
10.3.6 Italy Subcutaneous Injection Consumption (2017-2022)
-
10.3.7 Denmark Subcutaneous Injection Consumption (2017-2022)
-
10.3.8 Finland Subcutaneous Injection Consumption (2017-2022)
-
10.3.9 Norway Subcutaneous Injection Consumption (2017-2022)
-
10.3.10 Sweden Subcutaneous Injection Consumption (2017-2022)
-
10.3.11 Poland Subcutaneous Injection Consumption (2017-2022)
-
10.3.12 Russia Subcutaneous Injection Consumption (2017-2022)
-
10.3.13 Turkey Subcutaneous Injection Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Subcutaneous Injection Consumption (2017-2022)
-
10.4.2 Japan Subcutaneous Injection Consumption (2017-2022)
-
10.4.3 India Subcutaneous Injection Consumption (2017-2022)
-
10.4.4 South Korea Subcutaneous Injection Consumption (2017-2022)
-
10.4.5 Pakistan Subcutaneous Injection Consumption (2017-2022)
-
10.4.6 Bangladesh Subcutaneous Injection Consumption (2017-2022)
-
10.4.7 Indonesia Subcutaneous Injection Consumption (2017-2022)
-
10.4.8 Thailand Subcutaneous Injection Consumption (2017-2022)
-
10.4.9 Singapore Subcutaneous Injection Consumption (2017-2022)
-
10.4.10 Malaysia Subcutaneous Injection Consumption (2017-2022)
-
10.4.11 Philippines Subcutaneous Injection Consumption (2017-2022)
-
10.4.12 Vietnam Subcutaneous Injection Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Subcutaneous Injection Consumption (2017-2022)
-
10.5.2 Colombia Subcutaneous Injection Consumption (2017-2022)
-
10.5.3 Chile Subcutaneous Injection Consumption (2017-2022)
-
10.5.4 Argentina Subcutaneous Injection Consumption (2017-2022)
-
10.5.5 Venezuela Subcutaneous Injection Consumption (2017-2022)
-
10.5.6 Peru Subcutaneous Injection Consumption (2017-2022)
-
10.5.7 Puerto Rico Subcutaneous Injection Consumption (2017-2022)
-
10.5.8 Ecuador Subcutaneous Injection Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Subcutaneous Injection Consumption (2017-2022)
-
10.6.2 Kuwait Subcutaneous Injection Consumption (2017-2022)
-
10.6.3 Oman Subcutaneous Injection Consumption (2017-2022)
-
10.6.4 Qatar Subcutaneous Injection Consumption (2017-2022)
-
10.6.5 Saudi Arabia Subcutaneous Injection Consumption (2017-2022)
-
10.6.6 United Arab Emirates Subcutaneous Injection Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Subcutaneous Injection Consumption (2017-2022)
-
10.7.2 South Africa Subcutaneous Injection Consumption (2017-2022)
-
10.7.3 Egypt Subcutaneous Injection Consumption (2017-2022)
-
10.7.4 Algeria Subcutaneous Injection Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Subcutaneous Injection Consumption (2017-2022)
-
10.8.2 New Zealand Subcutaneous Injection Consumption (2017-2022)
11 Global Subcutaneous Injection Competitive Analysis
-
11.1 Takeda Pharmaceutical
-
11.1.1 Takeda Pharmaceutical Company Details
-
11.1.2 Takeda Pharmaceutical Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Takeda Pharmaceutical Subcutaneous Injection Main Business and Markets Served
-
11.1.4 Takeda Pharmaceutical Subcutaneous Injection Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Asahi Kasei Pharma
-
11.2.1 Asahi Kasei Pharma Company Details
-
11.2.2 Asahi Kasei Pharma Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Asahi Kasei Pharma Subcutaneous Injection Main Business and Markets Served
-
11.2.4 Asahi Kasei Pharma Subcutaneous Injection Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GSK
-
11.3.1 GSK Company Details
-
11.3.2 GSK Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GSK Subcutaneous Injection Main Business and Markets Served
-
11.3.4 GSK Subcutaneous Injection Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi
-
11.4.1 Sanofi Company Details
-
11.4.2 Sanofi Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi Subcutaneous Injection Main Business and Markets Served
-
11.4.4 Sanofi Subcutaneous Injection Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Becton Dickinson
-
11.5.1 Becton Dickinson Company Details
-
11.5.2 Becton Dickinson Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Becton Dickinson Subcutaneous Injection Main Business and Markets Served
-
11.5.4 Becton Dickinson Subcutaneous Injection Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 PenJet Corporation
-
11.6.1 PenJet Corporation Company Details
-
11.6.2 PenJet Corporation Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 PenJet Corporation Subcutaneous Injection Main Business and Markets Served
-
11.6.4 PenJet Corporation Subcutaneous Injection Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Endo International
-
11.7.1 Endo International Company Details
-
11.7.2 Endo International Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Endo International Subcutaneous Injection Main Business and Markets Served
-
11.7.4 Endo International Subcutaneous Injection Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Aspen Medical Group
-
11.8.1 Aspen Medical Group Company Details
-
11.8.2 Aspen Medical Group Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Aspen Medical Group Subcutaneous Injection Main Business and Markets Served
-
11.8.4 Aspen Medical Group Subcutaneous Injection Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Eli Lilly
-
11.9.1 Eli Lilly Company Details
-
11.9.2 Eli Lilly Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Eli Lilly Subcutaneous Injection Main Business and Markets Served
-
11.9.4 Eli Lilly Subcutaneous Injection Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Roche
-
11.10.1 Roche Company Details
-
11.10.2 Roche Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Roche Subcutaneous Injection Main Business and Markets Served
-
11.10.4 Roche Subcutaneous Injection Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Chugai Pharmaceutical
-
11.11.1 Chugai Pharmaceutical Company Details
-
11.11.2 Chugai Pharmaceutical Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Chugai Pharmaceutical Subcutaneous Injection Main Business and Markets Served
-
11.11.4 Chugai Pharmaceutical Subcutaneous Injection Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Eisai CO LTD
-
11.12.1 Eisai CO LTD Company Details
-
11.12.2 Eisai CO LTD Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Eisai CO LTD Subcutaneous Injection Main Business and Markets Served
-
11.12.4 Eisai CO LTD Subcutaneous Injection Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Antares Pharma Inc
-
11.13.1 Antares Pharma Inc Company Details
-
11.13.2 Antares Pharma Inc Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Antares Pharma Inc Subcutaneous Injection Main Business and Markets Served
-
11.13.4 Antares Pharma Inc Subcutaneous Injection Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Daiichi Sankyo
-
11.14.1 Daiichi Sankyo Company Details
-
11.14.2 Daiichi Sankyo Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Daiichi Sankyo Subcutaneous Injection Main Business and Markets Served
-
11.14.4 Daiichi Sankyo Subcutaneous Injection Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Subcutaneous Injection Market Outlook by Types and Applications to 2028
-
12.1 Global Subcutaneous Injection Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Subcutaneous Injection Equipment Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Subcutaneous Injection Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Subcutaneous Injection Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Subcutaneous Injection Market Analysis and Outlook to 2028
-
13.1 Global Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.2.2 Canada Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.2.3 Mexico Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.2 UK Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.3 Spain Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.4 Belgium Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.5 France Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.6 Italy Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.7 Denmark Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.8 Finland Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.9 Norway Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.10 Sweden Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.11 Poland Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.12 Russia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.3.13 Turkey Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.2 Japan Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.3 India Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.4 South Korea Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.8 Thailand Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.9 Singapore Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.11 Philippines Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.2 Colombia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.3 Chile Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.4 Argentina Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.6 Peru Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6.3 Oman Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6.4 Qatar Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.7.2 South Africa Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.7.3 Egypt Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.7.4 Algeria Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Subcutaneous Injection Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Subcutaneous Injection Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Subcutaneous Injection
-
Figure of Subcutaneous Injection Picture
-
Table Global Subcutaneous Injection Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Subcutaneous Injection Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Subcutaneous Injection Equipment Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Injection Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Injection Consumption by Country (2017-2022)
-
Table North America Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure United States Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Canada Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Mexico Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table Europe Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure Germany Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure UK Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Spain Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Belgium Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure France Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Italy Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Denmark Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Finland Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Norway Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Sweden Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Poland Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Russia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Turkey Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table APAC Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure China Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Japan Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure India Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure South Korea Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Thailand Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Singapore Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Philippines Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table South America Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure Brazil Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Colombia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Chile Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Argentina Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Peru Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table GCC Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure Bahrain Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Oman Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Qatar Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table Africa Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure Nigeria Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure South Africa Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Egypt Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure Algeria Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table Oceania Subcutaneous Injection Consumption by Country (2017-2022)
-
Figure Australia Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Subcutaneous Injection Consumption and Growth Rate (2017-2022)
-
Table Takeda Pharmaceutical Company Details
-
Table Takeda Pharmaceutical Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Subcutaneous Injection Main Business and Markets Served
-
Table Takeda Pharmaceutical Subcutaneous Injection Product Portfolio
-
Table Asahi Kasei Pharma Company Details
-
Table Asahi Kasei Pharma Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asahi Kasei Pharma Subcutaneous Injection Main Business and Markets Served
-
Table Asahi Kasei Pharma Subcutaneous Injection Product Portfolio
-
Table GSK Company Details
-
Table GSK Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Subcutaneous Injection Main Business and Markets Served
-
Table GSK Subcutaneous Injection Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Subcutaneous Injection Main Business and Markets Served
-
Table Sanofi Subcutaneous Injection Product Portfolio
-
Table Becton Dickinson Company Details
-
Table Becton Dickinson Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Subcutaneous Injection Main Business and Markets Served
-
Table Becton Dickinson Subcutaneous Injection Product Portfolio
-
Table PenJet Corporation Company Details
-
Table PenJet Corporation Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table PenJet Corporation Subcutaneous Injection Main Business and Markets Served
-
Table PenJet Corporation Subcutaneous Injection Product Portfolio
-
Table Endo International Company Details
-
Table Endo International Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo International Subcutaneous Injection Main Business and Markets Served
-
Table Endo International Subcutaneous Injection Product Portfolio
-
Table Aspen Medical Group Company Details
-
Table Aspen Medical Group Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Medical Group Subcutaneous Injection Main Business and Markets Served
-
Table Aspen Medical Group Subcutaneous Injection Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Subcutaneous Injection Main Business and Markets Served
-
Table Eli Lilly Subcutaneous Injection Product Portfolio
-
Table Roche Company Details
-
Table Roche Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Subcutaneous Injection Main Business and Markets Served
-
Table Roche Subcutaneous Injection Product Portfolio
-
Table Chugai Pharmaceutical Company Details
-
Table Chugai Pharmaceutical Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chugai Pharmaceutical Subcutaneous Injection Main Business and Markets Served
-
Table Chugai Pharmaceutical Subcutaneous Injection Product Portfolio
-
Table Eisai CO LTD Company Details
-
Table Eisai CO LTD Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai CO LTD Subcutaneous Injection Main Business and Markets Served
-
Table Eisai CO LTD Subcutaneous Injection Product Portfolio
-
Table Antares Pharma Inc Company Details
-
Table Antares Pharma Inc Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Antares Pharma Inc Subcutaneous Injection Main Business and Markets Served
-
Table Antares Pharma Inc Subcutaneous Injection Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Subcutaneous Injection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Subcutaneous Injection Main Business and Markets Served
-
Table Daiichi Sankyo Subcutaneous Injection Product Portfolio
-
Figure Global Subcutaneous Injection Equipment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Injection Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Table North America Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure United States Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure Germany Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure China Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure Brazil Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Subcutaneous Injection Consumption Forecast by Country (2022-2028)
-
Figure Australia Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)
-
